Coagulation and anticoagulation in extracorporeal membrane oxygenation

Artificial Organs

Volumn 23, Issue 11, 1999, Pages 979-983

  Muntean, W ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

Anticoagulation; Bleeding; Extracorporeal membrane oxygenation; Thrombosis

Indexed keywords

BLOOD VESSELS; OXYGENATION; PLATELETS; RESPIRATORY THERAPY; RISK ASSESSMENT;

% REDUCTIONS; ACTIVATED CLOTTING TIME; ANTI-COAGULATION; BLEEDINGS; EXTRACORPOREAL CIRCUITS; EXTRACORPOREAL MEMBRANE OXYGENATION; HAEMOSTASIS; HALF LIVES; PROTEASE INHIBITOR;

DISEASES;

ANTICOAGULATION; BLEEDING; BLOOD CLOTTING; CONFERENCE PAPER; ENZYME INHIBITION; EXTRACORPOREAL OXYGENATION; HEMOSTASIS; HEPARINIZATION; HUMAN; MONITORING; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE ADHESION; THROMBOGENESIS; THROMBOSIS;

EID: 0032750305     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.1999.06451.x     Document Type: Conference Paper

References (22)

1. Graves DF, Chemin JM, Kurusz M., Zwischenberger JB. Anticoagulation practices during neonatal extracorporeal membrane oxygenation: Survey results. Perfusion 1996;11:461-6.
2. Dela Cruz TV, Stewart DL, Winston SJ, Weatherman KS, Phleps JL, Mondoza JC. Risk factors for intracranial hemorrhage in the extracorporeal membrane oxygenation patient. J Perinatol 1997;17:18-23.
3. McManus ML, Kevy SV, Bower LK, Mickey PR. Coagulation factor deficiencies during initiation of extracorporeal membrane oxygenation. J Pediatr 1995;126:900-4.
4. Stallion A, Cofer BR, Rafferty JA, Ziegler MM, Ryckman FC. The significant relationship between platelet count and haemorrhagic complications on ECMO. Perfusion 1994;9:65-9.
5. Magovern GJ Jr, Magovern JA, Benckart DH, Lazzara RR, Sakert T, Maher TD Jr, Clark RE. Extracorporeal membrane oxygenation: preliminary results in patients with postcardiotomy cardiogenic shock. Ann Thorac Surg 1994;57:1462-8.
6. Stammers AH, Fristore LW, Christensen K, Deptla J, Sydzyik RT, Zavadil D, Willett L. Coagulopathic induced membrane dysfunction during extracorporeal membrane oxygenation: A case report. Perfusion 1997;12:143-9.
7. Colman RW. Platelet and neutrophil activation in cardiopulmonary bypass. Ann Thorac Surg 1990;49:32-4.
8. Svennevig JL, Geiran OR, Karlsen H, Pederson T, Mollnes TE, Kongsgard U, Froysaker T. Complement activation during extracorporeal circulation. J Thorac Cardiovasc Surg 1993;106:466-72.
9. Edmunds LH Jr. Blood surface interactions during cardiopulmonary bypass. J Card Surg 1993;8:404-10.
10. Klippenstein DL, Zerin JM, Hirschl RB, Donn SM. Splenic enlargement in neonates during ECMO. Radiology 1994;190: 411-2.
11. Urlesberger B, Zobel G, Zenz W, Kuttnig-Haim M, Maurer U, Reiterer F, Riccabona M, Dacar D, Gallistl S, Leschnik B, Muntean W. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr 1996;124:264-8.
12. Hirsch MD, Heparin. N Engl J Med 1991;324:1565-74.
13. Hirthler MA, Blackwell E, Abbe D, Doe Chapman R, LeClair Smith C, Goldthorn J, Canizaro P. Coagulation parameter instability as an early predictor of intracranial hemorrhage during extracorporeal membrane oxygenation. J Pediatr Surg 1992;27:40-3.
14. Elgue G, Blombäck M, Olsson P, Riesenfeld J. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin. Thromb Haemost 1993;70:289-93.
15. Palatianos GM, Dewanjee MK, Smith W, Novak S, Hsu LC, Kapadvanjwala M, Sfakinakis GN, Kaiser GA. Platelet preservation during cardiopulmonary bypass with iloprost and duraflo II heparin-coated surfaces. ASAIO Trans 1991;37:620-2.
16. Urlesberger B, Zobel G, Rödl S, Dacar D, Friehs I, Leschnik B, Muntean W. Activation of the clotting system: Heparincoated versus non coated systems for extracorporeal circulation, Int J Artif Organs 1997;20:708-12.
17. Nagaya M, Futamura M, Kato J, Miimi N, Fukata S. Application of a new anticoagulant (nafamostat mesilate) to control hemorrhagic complications during extracorporeal membrane oxygenation a preliminary report. J Pediatr Surg 1997;32:531-5.
18. Dickey LA, Butler TJ, Bergmann TM, Bates ME, Null DM. Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in a short term pig model. Perfusion 1994;9:327-33.
19. Wilson JM, Bower LK, Fackler JC, Beals DA, Bergus BO, Kevy SV. Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatric Surg 1993;28:436-40.
20. Shigeta O, Gluszko P, Downing SW, LU W, Niewiarowski S, Edmunds LH Jr. Protection of platelets during long term extracorporeal membrane oxygenation in sheep with a single dose of a disintegrin. Circulation 1992;86:398-404.
21. Pollock ME, Owings JT, Gosselin RC. ATIII Replacement during infant extracorporeal support. Thromb Haemost 1995; 73:936.
22. Chan AKC, Leaker M, Burrows FA, Williams WG, Gruenwald CE, Whyte L, Adams M, Brooker LA, Adams H, Mitchell L, Andrew M. Coagulation and fibrinolytic profile of pediatric patients undergoing cardiopulmonary bypass. Thromb Haemost 1997;77:70-7.